Skip to main content

Table 1 Patient demographics and clinical characteristics

From: Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix

 

SOX2

P16INK4A

HR-HPV RISH

Characteristic

n

Low

High

P

n

Neg.

Pos.

P

n

Neg.

Pos.

P

Age (years)

   

0.392

   

0.364

   

0.501

 <  44

40

16

24

 

40

4

36

 

40

8

32

 

 ≥ 44

48

15

33

 

48

8

40

 

48

7

41

 

HPV DNA (pg/ml)

   

0.983

   

0.514

   

0.028

 <  1

3

1

2

 

3

0

3

 

3

2

1

 

 ≥ 1

56

19

37

 

56

7

49

 

56

9

47

 

FIGO stage

   

0.178

   

0.816

   

0.021

 ≤ IIA

79

26

53

 

79

11

68

 

79

11

68

 

 ≥ IIB

9

5

4

 

9

1

8

 

9

4

5

 

Pre-operative Chemotherapy

   

0.084

   

0.681

   

0.007

 No

56

16

40

 

56

7

49

 

56

5

51

 

 Yes

32

15

17

 

32

5

27

 

32

10

22

 

Post-operative Chemotherapy

   

0.661

   

0.416

   

0.353

 No

4

1

3

 

4

0

4

 

4

0

4

 

 Yes

84

30

54

 

84

12

72

 

84

15

69

 

Post-operative Radiotherapy

   

0.120

   

0.109

   

0.826

 No

33

15

18

 

33

2

31

 

33

6

27

 

 Yes

55

16

39

 

55

10

45

 

55

9

46

 

Pathological type

   

0.699

   

0.473

   

0.014

 SCNEC -alone

66

24

42

 

66

10

56

 

66

15

51

 

 SCNEC -mix

22

7

15

 

22

2

20

 

22

0

22

 

Tumor size (cm)

   

0.358

   

0.112

   

0.896

 < 2

11

6

5

 

11

3

8

 

11

2

9

 

 2–4

40

13

27

 

40

7

33

 

40

6

34

 

 ≥4

37

12

25

 

37

2

35

 

37

7

30

 

Stromal invasion

   

0.948

   

0.225

   

0.281

 < 1/2

28

10

18

 

28

2

26

 

28

3

25

 

 ≥1/2

60

21

39

 

60

10

50

 

60

12

48

 

Endometrial invasion

   

0.178

   

0.816

   

0.170

 No

79

26

53

 

79

11

68

 

79

12

67

 

 Yes

9

5

4

 

9

1

8

 

9

3

6

 

Parametrium invasion

   

0.737

   

0.182

   

0.792

 No

78

27

51

 

78

12

66

 

78

13

65

 

 Yes

10

4

6

 

10

0

10

 

10

2

8

 

CIN

   

0.866

   

0.970

   

0.241

 No

73

26

47

 

73

10

63

 

73

14

59

 

 Yes

15

5

10

 

15

2

13

 

15

1

14

 

LNM

   

0.293

   

0.566

   

0.283

 No

52

16

36

 

52

8

44

 

52

7

45

 

 Yes

36

15

21

 

36

4

32

 

36

8

28

 

Nerve invasion

   

0.835

   

0.921

   

0.107

 No

67

24

43

 

67

9

58

 

67

9

58

 

 Yes

21

7

14

 

21

3

15

 

21

6

15

 

LVI

   

0.023

   

0.176

   

0.973

 No

29

15

14

 

29

6

23

 

29

5

24

 

 Yes

59

16

43

 

59

6

53

 

59

10

49

 

Relapse

   

0.023

   

0.297

   

0.027

 No

54

24

30

 

54

9

45

 

54

13

41

 

 Yes

34

7

27

 

34

3

31

 

34

2

32

 

N-marker

   

0.900

   

0.069

   

0.021

 ≤2 +

9

3

6

 

9

3

6

 

9

4

5

 

 > 2 +

79

28

51

 

79

9

70

 

79

11

68

 

MMR

   

0.737

   

0.182

   

0.792

 pMMR

78

27

51

 

78

12

66

 

78

13

65

 

 dMMR

10

4

6

 

10

0

10

 

10

2

8

 

Ki67(%)

   

0.105

   

0.005

   

0.154

 < 60

13

2

11

 

13

5

8

 

13

4

9

 

 ≥60

75

29

46

 

75

7

68

 

75

11

64

 
  1. CIN Cervical Intraepithelial Neoplasia, LNM Lymph Node Metastasis, LVI Lymphatic Vessel Invasion, N-marker Neuroendocrine-marker, MMR Mismatch Repair